| ORIGINAL ARTICLE |
|
| Year : 2020 | Volume
: 10
| Issue : 4 | Page : 229-234 |
|
|
Coronavirus Disease 2019 (COVID-19) and Vitamin D Status: Is there any Opportunity for Intervention?
Rizaldy Taslim Pinzon1, Winny Frida2, Vincent Ongko Wijaya1, Dessy Paramitha1, Patrick Nalla Nunsio1, Abraham Al Jody1
1 Duta Wacana Christian University School of Medicine, Yogyakarta; Bethesda Hospital, Yogyakarta, Indonesia
2 Bethesda Hospital, Yogyakarta, Indonesia
Correspondence Address:
Vincent Ongko Wijaya
Faculty of Medicine Duta Wacana Christian University, Dr. Wahidin Sudirohusodo Street Number 5-25, Yogyakarta 55224
Indonesia
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/ijnpnd.ijnpnd_48_20
|
|
|
Background and Aim: Coronavirus disease 2019 (COVID-19) is a newly emerging infectious disease that has affected every aspect of life in many countries. Previous studies suggested that the role of vitamin D in the immune system has certain significances in managing COVID-19 patients. This study aims to report the level of vitamin D in COVID-19 patients. Methods: We collected a series of confirmed cases from period of March through May 2020. The data collected including clinical symptoms, clinical signs, and laboratory examinations from 10 COVID-19 patients in Bethesda Hospital, Yogyakarta, Indonesia. This study used ELFA (enzyme-linked fluorescent assay) to measure vitamin D levels in serum or plasma. The collected data was analysed descriptively. Results: This study examined 10 patients with mean age of 49.6, ranging from 14 to 73 years old and most common age group was <60 years (60%). The gender ratio was equal between men and women (50:50). Most common symptoms were fatigue (60%) and fever (50%), whereas hypertension (40%) was the most common comorbidity. Most of patients (90%) had vitamin D deficiency (<20 ng/mL) and only 1 patient (10%) had insufficient vitamin D levels (<30 ng/mL). Conclusion: All of the COVID-19 patients in this study had suffered a decreased vitamin D levels, and more common in non-elderly patients. This is a novel findings of vitamin D deficiency in COVID-19 and has not been reported yet. Physicians should be aware in managing COVID-19 patients, especially the risk of vitamin D deficiency.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
